Novartis drug aids bones in Paget's disease-study (Reuters)


Reuters - A dose of the Novartis drug Zometa
halted bone deterioration and abnormal bone growth for at least
a year in about 95 percent of patients with Paget's disease, an
international study released on Wednesday showed.

Read more...